EUVIMEDEUVIMED entdecken
Open Access

Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair

Hongzhong Zhou, Liwen Zhu, Yajun Zhang, Lichan Chen, Dong-Mei Gou, Haohua Zhang, Rongmao Hua, Jianning Song, Chuanghua Qiu, Fu-Wen Yao, Xiafei Wei, Dayong Gu und 1 weitere

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.111142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Hongzhong Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Secon…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cell Cycle Proteins, Glycoproteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy resistance presents a major challenge in the treatment of hepatocellular carcinoma (HCC), with the underlying molecular mechanisms largely unknown. This study aimed to investigate the role of tissue factor pathway inhibitor 2 (TFPI2) in modulating HCC chemosensitivity. We explored the impact of TFPI2 on sorafenib sensitivity in patient-derived organoids and mouse models using immunofluorescence analysis, chromatin immunoprecipitation, and RNA immunoprecipitation. We observed the downregulation of TFPI2 in HCC, and its deletion in mice (TFPI2HKO) accelerated DEN-induced liver tumorigenesis. Notably, TFPI2 overexpression increased sorafenib sensitivity in HCC organoids and in vivo models. Mechanistic insights indicated that TFPI2 stabilizes the mRNA of growth arrest and DNA damage-inducible alpha (GADD45A) by engaging the cell cycle and apoptosis regulator 2 (CCAR2), promoting GADD45A-mediated DNA damage and inhibiting homologous recombination repair. Furthermore, TFPI2 protects CCAR2 from ubiquitination-induced degradation by associating with the deubiquitinating enzyme BRCC3. We identified polydatin, a resveratrol glycoside, which upregulates TFPI2 and synergistically enhances the chemosensitizing effect of sorafenib in organoids and in vivo. TFPI2 plays a critical role in CCAR2-GADD45A-induced DNA damage repair, providing a strategy to enhance HCC chemosensitivity. Our findings elucidate the molecular intricacies of chemoresistance in HCC and reveal a potential therapeutic target for alleviating this resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCell Cycle ProteinsGlycoproteinsNuclear ProteinsAnimalsMiceHumansDNA DamageSorafenibDNA RepairMaleCell Line, TumorGADD45 Proteins

Stichwörter der Autor:innen

TFPI2chemoresistancehepatocellular carcinomamRNA stabilityorganoid

Substanzen

tissue-factor-pathway inhibitor 2SorafenibCell Cycle ProteinsGlycoproteinsGADD45A protein, humanNuclear ProteinsGADD45 Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Medical Innovation Technology Transformation Cent…
  • Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fujian Medical University, China.
  • Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
  • Leland Stanford Junior University, USA.
  • Guangdong Provincial Clinical Research Center for Laboratory Medicine, China.

Zitieren

APA

Zhou, H., Zhu, L., Zhang, Y., Chen, L., Gou, D. M., Zhang, H., Hua, R., Song, J., Qiu, C., Yao, F. W., Wei, X., Gu, D., & Xu, Y. (2025). Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.111142

Vancouver

Zhou H, Zhu L, Zhang Y, Chen L, Gou DM, Zhang H, et al. Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.111142

BibTeX
@article{Zhou2025,
  author = {Zhou, Hongzhong and Zhu, Liwen and Zhang, Yajun and Chen, Lichan and Gou, Dong-Mei and Zhang, Haohua and Hua, Rongmao and Song, Jianning and Qiu, Chuanghua and Yao, Fu-Wen and Wei, Xiafei and Gu, Dayong and Xu, Yong},
  title = {Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.111142}
}
Kostenlos starten →